Livzon Pharmaceutical Group ( (HK:1513) ) has provided an announcement.
Livzon Pharmaceutical Group has announced a capital contribution of RMB1 billion to its subsidiary, LivzonBio, increasing its stake from 60.23% to 66.54%. This strategic move is part of a connected transaction under Hong Kong Listing Rules, aimed at strengthening LivzonBio’s financial position and enhancing the company’s influence in the biotech sector.
More about Livzon Pharmaceutical Group
Livzon Pharmaceutical Group operates in the pharmaceutical industry, focusing on the development and production of a wide range of pharmaceutical products. The company is known for its innovative approach in creating healthcare solutions and has a significant market presence in China.
YTD Price Performance: -1.45%
Technical Sentiment Signal: Strong Sell
Current Market Cap: $3.99B
See more insights into 1513 stock on TipRanks’ Stock Analysis page.